title: The year in cardiology 2014: coronary intervention.
authors.affiliation: Manchester Heart Centre, Manchester Royal Infirmary, Manchester, UK.
authors.forename: Javaid
authors.initials: J
authors.lastname: Iqbal
authors.affiliation: Erasmus Medical Centre, Rotterdam, the Netherlands Imperial College, London, UK.
authors.forename: Patrick W
authors.initials: PW
authors.lastname: Serruys
authors.affiliation: Montefiore Medical Centre, Albert Einstein College of Medicine, New York, NY, USA.
authors.forename: Felipe N
authors.initials: FN
authors.lastname: Albuquerque
authors.affiliation: Cardiovascular Research Centre, OLV Hospital, Aalst, Belgium william.wijns@olvz-aalst.be.
authors.forename: William
authors.initials: W
authors.lastname: Wijns
mesh_terms: D020341:Absorbable Implants / Q000639:trends; D054058:Acute Coronary Syndrome / Q000601:surgery*; D000925:Anticoagulants / Q000627:therapeutic use; D001547:Benzaldehydes / Q000627:therapeutic use; D001026:Coronary Artery Bypass / Q000639:trends; D003324:Coronary Artery Disease / Q000517:prevention & control; D054855:Drug-Eluting Stents / Q000639:trends; D053805:Fractional Flow Reserve, Myocardial / Q000502:physiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000601:surgery; D009204:Myocardial Revascularization / Q000639:trends*; D010091:Oximes / Q000627:therapeutic use; D062645:Percutaneous Coronary Intervention / Q000639:trends*; D064801:Phospholipase A2 Inhibitors / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011108:Polymers; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases / Q000037:antagonists & inhibitors; D012697:Serine Endopeptidases; D015607:Stents / Q000639:trends; D017131:Thrombectomy / Q000639:trends; D054457:Tissue Scaffolds / Q000639:trends; D001713:Biphenyl Compounds; D004048:Diethylamines; D011744:Pyrimidinones; D013440:Sulfides
chemical_list: D000925:Anticoagulants; D001547:Benzaldehydes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010091:Oximes; D064801:Phospholipase A2 Inhibitors; D010975:Platelet Aggregation Inhibitors; D011108:Polymers; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases; C472125:PCSK9 protein, human; C529040:darapladib; D001713:Biphenyl Compounds; D004048:Diethylamines; D011744:Pyrimidinones; D013440:Sulfides